- Home
- BIRD vs ZYXI Comparison
BIRD vs ZYXI Comparison
Compare BIRD & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRD
- ZYXI
- Stock Information
- Founded
- BIRD 2015
- ZYXI 1996
- Country
- BIRD United States
- ZYXI United States
- Employees
- BIRD N/A
- ZYXI N/A
- Industry
- BIRD Apparel
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BIRD Consumer Discretionary
- ZYXI Health Care
- Exchange
- BIRD Nasdaq
- ZYXI Nasdaq
- Market Cap
- BIRD 89.7M
- ZYXI 72.3M
- IPO Year
- BIRD 2021
- ZYXI N/A
- Fundamental
- Price
- BIRD $7.03
- ZYXI $1.52
- Analyst Decision
- BIRD Buy
- ZYXI Hold
- Analyst Count
- BIRD 2
- ZYXI 3
- Target Price
- BIRD $11.00
- ZYXI $3.00
- AVG Volume (30 Days)
- BIRD 71.5K
- ZYXI 536.0K
- Earning Date
- BIRD 08-07-2025
- ZYXI 07-31-2025
- Dividend Yield
- BIRD N/A
- ZYXI N/A
- EPS Growth
- BIRD N/A
- ZYXI N/A
- EPS
- BIRD N/A
- ZYXI N/A
- Revenue
- BIRD $170,646,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- BIRD N/A
- ZYXI N/A
- Revenue Next Year
- BIRD $5.16
- ZYXI $19.55
- P/E Ratio
- BIRD N/A
- ZYXI N/A
- Revenue Growth
- BIRD N/A
- ZYXI N/A
- 52 Week Low
- BIRD $3.93
- ZYXI $1.23
- 52 Week High
- BIRD $18.33
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- BIRD 34.55
- ZYXI 37.51
- Support Level
- BIRD $6.55
- ZYXI $1.37
- Resistance Level
- BIRD $10.54
- ZYXI $1.67
- Average True Range (ATR)
- BIRD 0.78
- ZYXI 0.22
- MACD
- BIRD -0.36
- ZYXI -0.03
- Stochastic Oscillator
- BIRD 22.28
- ZYXI 21.17
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.